Orthofix Medical Inc.
General ticker "OFIX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $575.6M (TTM average)
Orthofix Medical Inc. follows the US Stock Market performance with the rate: 28.9%.
Estimated limits based on current volatility of 2.6%: low 14.04$, high 14.79$
Factors to consider:
- Total employees count: 1616 (-1.1%) as of 2024
- US accounted for 84.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Product liability, Integration challenges, Regulatory and compliance, IT system disruptions
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.18$, 27.70$]
- 2025-12-31 to 2026-12-31 estimated range: [14.08$, 27.39$]
Financial Metrics affecting the OFIX estimates:
- Negative: with PPE of -54.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: 42.53 < Shareholder equity ratio, % of 56.32 <= 64.17
- Negative: negative Net income
- Positive: Inventory ratio change, % of -3.77 <= -0.76
Short-term OFIX quotes
Long-term OFIX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $460.71MM | $746.64MM | $799.49MM |
| Operating Expenses | $473.98MM | $885.75MM | $884.11MM |
| Operating Income | $-13.27MM | $-139.11MM | $-84.62MM |
| Non-Operating Income | $-4.44MM | $-9.57MM | $-39.26MM |
| Interest Expense | $1.29MM | $8.63MM | $29.63MM |
| R&D Expense | $49.06MM | $80.23MM | $73.64MM |
| Income(Loss) | $-17.71MM | $-148.68MM | $-123.88MM |
| Taxes | $2.04MM | $2.72MM | $2.12MM |
| Profit(Loss)* | $-19.75MM | $-151.40MM | $-126.00MM |
| Stockholders Equity | $336.86MM | $598.73MM | $503.12MM |
| Inventory | $100.15MM | $222.17MM | $189.45MM |
| Assets | $458.63MM | $925.32MM | $893.29MM |
| Operating Cash Flow | $-11.54MM | $-45.75MM | $25.79MM |
| Capital expenditure | $23.16MM | $62.05MM | $34.88MM |
| Investing Cash Flow | $-24.53MM | $-33.13MM | $-27.58MM |
| Financing Cash Flow | $-0.08MM | $65.32MM | $50.71MM |
| Earnings Per Share** | $-0.98 | $-4.12 | $-3.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.